Perampanel (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Perampanel" in English language version.

refsWebsite

Global rank English rank

11nih.gov

4^th place

5doi.org

2^nd place

4semanticscholar.org

11^th place

8^th place

3tga.gov.au

3,984^th place

2,622^nd place

2web.archive.org

1^st place

2fda.gov

447^th place

338^th place

1nps.org.au

low place

1in.gov.br

3,151^st place

5,932^nd place

1canada.ca

1,712^th place

1,063^rd place

1europa.eu

68^th place

117^th place

1springer.com

274^th place

309^th place

1iqwig.de

low place

1harvard.edu

18^th place

17^th place

canada.ca

"Product monograph brand safety updates". Health Canada. February 2024. Retrieved 24 March 2024.

doi.org

Besag FM, Patsalos PN (2016). "Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures". Neuropsychiatric Disease and Treatment. 12: 1215–20. doi:10.2147/NDT.S83842. PMC 4876101. PMID 27274257. S2CID 14176469.
Chong DJ, Lerman AM (April 2016). "Practice Update: Review of Anticonvulsant Therapy". Current Neurology and Neuroscience Reports. 16 (4): 39. doi:10.1007/s11910-016-0640-y. PMID 26984292. S2CID 9090302.
Rogawski MA (March 2011). "Revisiting AMPA receptors as an antiepileptic drug target". Epilepsy Currents. 11 (2): 56–63. doi:10.5698/1535-7511-11.2.56. PMC 3117497. PMID 21686307. S2CID 15246804.
Rogawski MA, Hanada T (2013). "Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist". Acta Neurologica Scandinavica. Supplementum. 127 (197): 19–24. doi:10.1111/ane.12100. PMC 4506647. PMID 23480152.
Chen CY, Matt L, Hell JW, Rogawski MA (17 September 2014). "Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons". PLOS ONE. 9 (9): e108021. Bibcode:2014PLoSO...9j8021C. doi:10.1371/journal.pone.0108021. PMC 4168215. PMID 25229608. S2CID 7519077.

europa.eu

ema.europa.eu

EMA Summary of Product Characteristics Archived 20 September 2018 at the Wayback Machine. "Index pagel". 17 September 2018. Archived from the original on 20 June 2018. Retrieved 21 August 2012.

fda.gov

nctr-crs.fda.gov

"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.

fda.gov

Yang X, Wu TC, Yuxin MA, Lee JY, Bhattaram VA, Mehta MU. "U.S. FDA Clinical Pharmacology Review. Fycompa (perampanel)" (PDF): 25. {{cite journal}}: Cite journal requires |journal= (help)

harvard.edu

ui.adsabs.harvard.edu

Chen CY, Matt L, Hell JW, Rogawski MA (17 September 2014). "Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons". PLOS ONE. 9 (9): e108021. Bibcode:2014PLoSO...9j8021C. doi:10.1371/journal.pone.0108021. PMC 4168215. PMID 25229608. S2CID 7519077.

in.gov.br

Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.

iqwig.de

Institute for Quality Efficiency in Health Care (13 August 2014). "Perampanel -- Benefit Assessment According to §35a Social Code Book V [Internet]" (PDF). Extract of Dossier Assessment No. A14-16. IQWiG Dossier Assessment Extracts. PMID 26677496.

nih.gov

nps.org.au

"Fycompa". NPS MedicineWise. 15 July 2021. Retrieved 19 February 2022.

semanticscholar.org

api.semanticscholar.org

Besag FM, Patsalos PN (2016). "Clinical efficacy of perampanel for partial-onset and primary generalized tonic-clonic seizures". Neuropsychiatric Disease and Treatment. 12: 1215–20. doi:10.2147/NDT.S83842. PMC 4876101. PMID 27274257. S2CID 14176469.
Chong DJ, Lerman AM (April 2016). "Practice Update: Review of Anticonvulsant Therapy". Current Neurology and Neuroscience Reports. 16 (4): 39. doi:10.1007/s11910-016-0640-y. PMID 26984292. S2CID 9090302.
Rogawski MA (March 2011). "Revisiting AMPA receptors as an antiepileptic drug target". Epilepsy Currents. 11 (2): 56–63. doi:10.5698/1535-7511-11.2.56. PMC 3117497. PMID 21686307. S2CID 15246804.
Chen CY, Matt L, Hell JW, Rogawski MA (17 September 2014). "Perampanel inhibition of AMPA receptor currents in cultured hippocampal neurons". PLOS ONE. 9 (9): e108021. Bibcode:2014PLoSO...9j8021C. doi:10.1371/journal.pone.0108021. PMC 4168215. PMID 25229608. S2CID 7519077.

springer.com

adisinsight.springer.com

"Perampanel". AdisInsight. Retrieved 29 August 2016.

tga.gov.au

"AusPAR: Perampanel hemisesquihydrate". Therapeutic Goods Administration (TGA). 10 May 2021. Retrieved 12 June 2021.
"Prescription medicines: registration of new chemical entities in Australia, 2014". Therapeutic Goods Administration (TGA). 21 June 2022. Retrieved 10 April 2023.

ebs.tga.gov.au

"TGA eBS - Product and Consumer Medicine Information Licence".

web.archive.org

Anvisa (31 March 2023). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 4 April 2023). Archived from the original on 3 August 2023. Retrieved 16 August 2023.
EMA Summary of Product Characteristics Archived 20 September 2018 at the Wayback Machine. "Index pagel". 17 September 2018. Archived from the original on 20 June 2018. Retrieved 21 August 2012.

Perampanel (English Wikipedia)

canada.ca

doi.org

europa.eu

ema.europa.eu

fda.gov

nctr-crs.fda.gov

fda.gov

harvard.edu

ui.adsabs.harvard.edu

in.gov.br

iqwig.de

nih.gov

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

dailymed.nlm.nih.gov

nps.org.au

semanticscholar.org

api.semanticscholar.org

springer.com

adisinsight.springer.com

tga.gov.au

tga.gov.au

ebs.tga.gov.au

web.archive.org